SCHEMBL7089562

SCHEMBL7089562

CN(C)c1ccc(-c2cccc3[nH]ccc23)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 3/20 0.58
PIK3CB P42338 2/20 0.48
PIK3CG P48736 1/20 0.47
ASH1L Q9NR48 1/20 0.47
MAPT P10636 1/20 0.46
CSNK2B P67870 1/20 0.43
CSNK2A1 P68400 1/20 0.43
PIP4K2A P48426 1/20 0.43
PIP4K2B P78356 1/20 0.43
PIP4K2C Q8TBX8 1/20 0.43
AHR P35869 1/20 0.42
HPGDS O60760 4/20 0.41
CHEK1 O14757 1/20 0.40
CHRNA7 P36544 2/20 0.40
KCNH2 Q12809 2/20 0.40
IKBKB O14920 1/20 0.39
ATM Q13315 1/20 0.39
S1PR1 P21453 1/20 0.38
S1PR3 Q99500 1/20 0.38
BRD4 O60885 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10945814 0.82 PIK3CD (0.75) PIK3CDPIK3CBPIK3CGASH1LCSNK2B
SCHEMBL13115632 0.81 PIK3CD (0.64) PIK3CDPIK3CBPIK3CGASH1LMAPT
SCHEMBL4794016 0.80 PIK3CD (0.48) PIK3CDPIK3CBPIK3CGASH1LCSNK2B
SCHEMBL27725234 0.79 PIK3CD (0.66) PIK3CDPIK3CBPIK3CGASH1LCSNK2B
SCHEMBL29712113 0.78 PIK3CD (0.70) PIK3CDPIK3CBPIK3CGASH1LCSNK2B
SCHEMBL2193011 0.78 PIK3CD (0.70) PIK3CDPIK3CBPIK3CGASH1LCSNK2B
SCHEMBL6321966 0.77 PIK3CD (0.64) PIK3CDPIK3CBPIK3CGASH1LCSNK2B
SCHEMBL6322061 0.77 PIK3CD (0.64) PIK3CDPIK3CBPIK3CGASH1LMAPT
SCHEMBL27504678 0.77 PIK3CD (0.64) PIK3CDPIK3CBPIK3CGASH1LCSNK2B
SCHEMBL6322152 0.77 PIK3CD (0.64) PIK3CDPIK3CBPIK3CGASH1LMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203959-A1 Novel modulators of potassium channels 4SC AG (DE) 2003-10-30 US disclosed
WO-2003074047-A1 INDOLE DERIVATIVES AS MODULATORS OF POTASSIUM CHANNELS 4SC AG (DE) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203959-A1 Novel modulators of potassium channels HCN3, KCNN3, KCNN1 PIK3CD 3331/4885PIK3CB 3767/4885PIK3CG 3655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.